原著 |
|
|
|
|
氯氧喹通过下调Rho/Rho激酶信号通路抑制乳腺癌细胞转移 |
刘婧雯1( ),杨兴莲1,沈凯莉1,曾玲晖1,*( ),孙燕2,*( ) |
1. 浙江大学城市学院医学院, 浙江 杭州 310015 2. 浙江省肿瘤医院综合肿瘤内科, 浙江 杭州 310022 |
|
Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway |
LIU Jingwen1( ),YANG Xinglian1,SHEN Kaili1,ZENG Linghui1,*( ),SUN Yan2,*( ) |
1. School of Medicine, Zhejiang University City College, Hangzhou 310015, China 2. Department of Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China |
引用本文:
刘婧雯,杨兴莲,沈凯莉,曾玲晖,孙燕. 氯氧喹通过下调Rho/Rho激酶信号通路抑制乳腺癌细胞转移[J]. 浙江大学学报(医学版), 2019, 48(6): 631-637.
LIU Jingwen,YANG Xinglian,SHEN Kaili,ZENG Linghui,SUN Yan. Chloroxoquinoline inhibits invasion in breast cancer via down-regulating Rho/Rho kinase signaling pathway. J Zhejiang Univ (Med Sci), 2019, 48(6): 631-637.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.12.07
或
http://www.zjujournals.com/med/CN/Y2019/V48/I6/631
|
1 |
YOULDEN D R , CRAMB S M , YIP C H et al. Incidence and mortality of female breast cancer in the Asia-Pacific region[J]. Cancer Biol Med, 2014, 11 (2): 101- 115
|
2 |
SUNG H , ROSENBERG P S , CHEN W Q et al. Female breast cancer incidence among Asian and Western populations:more similar than expected[J]. J Natl Cancer Inst, 2015, 107 (7): pii:djv107
|
3 |
耿维凤 . 抗癌新药-氯氧喹胶囊[J]. 中国医院药学杂志, 2005, 25 (10): 994 GENG Weifeng . Anticancer drug-chloroxoquinoline capsule[J]. Chinese Journal of Hospital Pharmacy, 2005, 25 (10): 994
doi: 10.3321/j.issn:1001-5213.2005.10.055
|
4 |
孙燕, 冯琳迤, 雷蕾 et al. 氯氧喹对不同类型乳腺癌细胞系的抑制作用及机制[J]. 中国药理学通报, 2019, 35 (3): 347- 353 SUN Yan , FENG Linyi , LEI Lei et al. Inhibitory effect of chloroxoquinoline in different breast cancer cells[J]. Chinese Pharmacological Bulletin, 2019, 35 (3): 347- 353
doi: 10.3969/j.issn.1001-1978.2019.03.011
|
5 |
OLSON M F . Applications for ROCK kinase inhibition[J]. Current Opinion in Cell Biology, 2008, 20 (2): 242- 248
doi: 10.1016/j.ceb.2008.01.002
|
6 |
肖英, 程爱兰 . 细胞骨架在肿瘤侵袭转移中的研究进展[J]. 中国肿瘤临床, 2016, 43 (22): 1007- 1011 XIAO Ying , CHENG Ailan . Cell cytoskeleton-the movers in cancer metastasis[J]. Chinese Journal of Clinical Oncology, 2016, 43 (22): 1007- 1011
doi: 10.3969/j.issn.1000-8179.2016.22.828
|
7 |
ROTTNER K , STRADAL T E . Actin dynamics and turnover in cell motility[J]. Curr Opin Cell Biol, 2011, 23 (5): 569- 578
doi: 10.1016/j.ceb.2011.07.003
|
8 |
AYLETT C H , L?WE J , AMOS L A . New insights into the mechanisms of cytomotive actin and tubulin filaments[J]. Int Rev Cell Mol Biol, 2011, 292 1- 71
doi: 10.1016/B978-0-12-386033-0.00001-3
|
9 |
FRANCIS R, XU X, PARK H, et al. Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics[J/OL]. PLoS One, 2011, 6(10): e26379.
|
10 |
KATSETOS C D , DRáBEROVá E , LEGIDO A et al. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. Ⅱ. γ-Tubulin[J]. J Cell Physiol, 2009, 221 (3): 514- 520
doi: 10.1002/jcp.21884
|
11 |
PRICE L S , COLLARD J G . Regulation of the cytoskeleton by Rho-familyGTPases:implications for tumour cell invasion[J]. Semin Cancer Biol, 2001, 11 (2): 167- 173
doi: 10.1006/scbi.2000.0367
|
12 |
TAKAHASHI N , NOBUSUE H , SHIMIZU T et al. ROCK inhibition induces terminal adipocyte differentiation and suppresses tumorigenesis in chemoresistant osteosarcoma cells[J]. Cancer Res, 2019, 79 (12): 3088- 3099
doi: 10.1158/0008-5472.CAN-18-2693
|
13 |
CASCIONE M , DE MATTEIS V , TOMA C C et al. Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells[J]. Exp Cell Res, 2017, 360 (2): 303- 309
doi: 10.1016/j.yexcr.2017.09.020
|
14 |
HUANG G X , WANG Y , SU J et al. Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma[J]. Cancer Lett, 2017, 410 1- 11
doi: 10.1016/j.canlet.2017.09.005
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|